胎儿生长障碍和动脉和周围动脉动脉硬化
C N Martyn1, C R Gale, S Jespersen
1MRC Environmental Epidemiology Unit, Southampton General Hospital, UK. c.martyn@mrc.soton.ac.uk
Lancet (London, England)
|July 31, 1998
概括
低出生体重与动脉样硬化增加有关,特别是在动脉中. 胎儿生长障碍可能导致长期的血管变化,增加成人心血管疾病的风险.
科学领域:
- 血管生物学 血管生物学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 流行病学研究表明,低出生体重的成年人患冠心病和中风的风险更高.
- 连接低出生体重与成人心血管疾病的机制尚不清楚.
- 动脉样硬化是心血管疾病发展的关键因素.
研究的目的:
- 为了调查胎儿生长受损,出生时体重低是否会增加动脉样硬化风险.
- 根据可用的出生体重数据,评估70岁左右的个体的动脉和下肢动脉.
主要方法:
- 这项研究包括322名参与者 (在2232名出生于1922-1926年的2232人中) 拥有可用的出生记录.
- 在181名参与者中通过双重超声扫描评估了动脉动脉样硬化.
- 在186名参与者中,使用脚-手臂压力指数 (ABPI) 评估下肢动脉样硬化.
主要成果:
- 最低的出生体重与动脉动脉样硬化的最大患病率和严重程度有关.
- 出生时体重为6.5磅或更少的个体患上动脉狭窄症的风险明显更高 (OR 5.3).
- 在出生体重最低的个体中观察到下肢动脉硬化增加的趋势,但在统计学上不显著 (OR 2.3).
结论:
- 增加动脉动脉生成 (斑块积累) 是一个潜在的机制,将受损的胎儿生长与心血管疾病联系起来.
- 胎儿生长限制可能会导致血管结构和新陈代谢的持久变化.
- 低出生体重是成人动脉样硬化,特别是动脉疾病的重要危险因素.
相关概念视频
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...


